Add Yahoo as a preferred source to see more of our stories on Google. https://www.tipranks.com/news/the-fly/crispr-therapeutics-price-target-raised-to-82-from-80-at ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 biomarker test – the first in-vitro diagnostic (IVD) immunoassay to identify ...
INDIANAPOLIS, Oct. 13, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181 test, the only ...
INDIANAPOLIS, Dec. 5, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated ...
(RTTNews) - Swiss drug major Roche (RHHBY) announced Wednesday the launch of Elecsys EBV panel in countries accepting the CE Mark. The company said it plans to file for approval with the FDA in the ...
Redcliffe Labs has launched the Elecsys AMH Plus blood test in collaboration with Roche Diagnostics India to support identification of Polycystic Ovarian Morphology (PCOM) and aid in the diagnosis of ...
As cyber security requirements expand for the industrial data systems used within the nation's critical infrastructure, the Elecsys zONeGUARD provides a security solution for industrial communication ...
Elecsys Corp. (www.elecsyscorp.com), an Olathe, Kansas-based provider of machine-to-machine (M2M) communication technology solutions, integrated displays and custom electronics for critical industrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results